Keyphrases
Beta-blockers
100%
Patients with Chronic Heart Failure
100%
Angiotensin II (Ang II)
100%
Vasopressor Responses
100%
Angiotensin II Infusion
100%
Carvedilol
100%
Metoprolol
66%
Radial Artery
33%
Systolic Pressure
33%
Synergistic Interaction
16%
Vascular Reactivity
16%
Chronic Heart Failure
16%
New York Heart Association Class
16%
Left Ventricular Ejection Fraction
16%
Maximum Tolerated Dose
16%
Non-selective
16%
Angiotensin II Type 1 Receptor (AT1R)
16%
Block Properties
16%
Adrenergic Receptors
16%
Enalapril
16%
Intravenous Injection
16%
ACE Inhibitor Therapy
16%
Selective Antagonist
16%
Ancillary
16%
Nursing and Health Professions
Hypertensive Factor
100%
Infusion
100%
Angiotensin II
100%
Congestive Heart Failure
100%
Carvedilol
66%
Metoprolol
44%
Systolic Blood Pressure
22%
Intravenous Drug Administration
11%
New York Heart Association Class
11%
Dipeptidyl Carboxypeptidase Inhibitor
11%
Heart Left Ventricle Ejection Fraction
11%
Maximum Tolerated Dose
11%
Angiotensin Blood Level
11%
Receptor
11%
Enalapril
11%
Adrenergic Receptor
11%
Pharmacology, Toxicology and Pharmaceutical Science
Angiotensin II
100%
Hypertensive Factor
100%
Congestive Heart Failure
100%
Carvedilol
66%
Metoprolol
44%
Receptor
11%
Maximum Tolerated Dose
11%
Synergism
11%
Adrenergic Receptor
11%
Dipeptidyl Carboxypeptidase Inhibitor
11%
Enalapril
11%